Clinical Trials

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer


Study ID
Alliance A011502

NCT Number
NCT02927249 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0009

Principle Investigator
Dr. Deena Graham

Phase
III

Sponsor
Alliance


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now